{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T16:58:40Z","timestamp":1793293120390,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s00210-021-02106-1","type":"journal-article","created":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T05:53:07Z","timestamp":1622526787000},"page":"1917-1928","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Ellagic acid prevents 3-nitropropionic acid induced symptoms of Huntington\u2019s disease"],"prefix":"10.1007","volume":"394","author":[{"given":"Priya","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6697-544X","authenticated-orcid":false,"given":"Manish","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2792-7469","authenticated-orcid":false,"given":"Nitin","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,1]]},"reference":[{"issue":"1","key":"2106_CR1","doi-asserted-by":"publisher","first-page":"60","DOI":"10.4103\/0976-500X.107685","volume":"4","author":"SS Ambrose","year":"2013","unstructured":"Ambrose SS, Solairaj P, Subramoniam A (2013) Effectiveness of ellagic acid on isoniazid-rifampicin induced liver damage in rats. J Pharmacol Pharmacother 4(1):60\u201362. https:\/\/doi.org\/10.4103\/0976-500X.107685","journal-title":"J Pharmacol Pharmacother"},{"issue":"6","key":"2106_CR2","doi-asserted-by":"publisher","first-page":"e13217","DOI":"10.1111\/jfbc.13217","volume":"44","author":"A Aslan","year":"2020","unstructured":"Aslan A, Gok O, Beyaz S, Arslan E, Erman O, Agca CA (2020) The preventive effect of ellagic acid on brain damage in rats via regulating of Nrf-2, NF-kB and apoptotic pathway. J Food Biochem 44(6):e13217. https:\/\/doi.org\/10.1111\/jfbc.13217","journal-title":"J Food Biochem"},{"key":"2106_CR3","doi-asserted-by":"publisher","first-page":"360438","DOI":"10.1155\/2014\/360438","volume":"2014","author":"MMF Ayala","year":"2014","unstructured":"Ayala MMF, Arguelles S (2014) Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid Med Cell Longev 2014:360438. https:\/\/doi.org\/10.1155\/2014\/360438","journal-title":"Oxid Med Cell Longev"},{"key":"2106_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.brainres.2017.02.021","volume":"1662","author":"T Baluchnejadmojarad","year":"2017","unstructured":"Baluchnejadmojarad T, Rabiee N, Zabihnejad S, Roghani M (2017) Ellagic acid exerts protective effect in intrastriatal 6-hydroxydopamine rat model of Parkinson\u2019s disease: possible involvement of ER\u03b2\/Nrf2\/HO-1 signaling. Brain Res 1662:23\u201330. https:\/\/doi.org\/10.1016\/j.brainres.2017.02.021","journal-title":"Brain Res"},{"issue":"6","key":"2106_CR5","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1111\/j.1471-4159.2005.03515.x","volume":"95","author":"E Brouillet","year":"2005","unstructured":"Brouillet E, Jacquard C, Bizat N, Blum D (2005) 3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington\u2019s disease. J Neurochem 95(6):1521\u20131540. https:\/\/doi.org\/10.1111\/j.1471-4159.2005.03515.x","journal-title":"J Neurochem"},{"key":"2106_CR6","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/978-3-319-71779-1_3","volume":"1049","author":"C Carmo","year":"2018","unstructured":"Carmo C, Naia L, Lopes C, Rego AC (2018) Mitochondrial dysfunction in Huntington\u2019s disease. Adv Exp Med Biol 1049:59\u201383. https:\/\/doi.org\/10.1007\/978-3-319-71779-1_3","journal-title":"Adv Exp Med Biol"},{"key":"2106_CR7","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1038\/s41598-018-19732-0","volume":"8","author":"P Chen","year":"2018","unstructured":"Chen P, Chen F, Zhou B (2018) Antioxidative, anti-inflammatory and anti-apoptotic effects of ellagic acid in liver and brain of rats treated by D-galactose. Sci Rep 8:1465. https:\/\/doi.org\/10.1038\/s41598-018-19732-0","journal-title":"Sci Rep"},{"key":"2106_CR8","first-page":"283","volume-title":"CRC handbook of methods for oxygen radical research","author":"A Claiborne","year":"1985","unstructured":"Claiborne A (1985) Catalase activity. In: Greenwald RA (ed) CRC handbook of methods for oxygen radical research. CRC Press, Boca Raton, pp 283\u2013284"},{"issue":"6","key":"2106_CR9","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1007\/s11064-016-1853-9","volume":"41","author":"MR de Oliveira","year":"2016","unstructured":"de Oliveira MR (2016) The effects of ellagic acid upon brain cells: a mechanistic view and future directions. Neurochem Res 41(6):1219\u20131228. https:\/\/doi.org\/10.1007\/s11064-016-1853-9","journal-title":"Neurochem Res"},{"key":"2106_CR10","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.biopha.2015.11.009","volume":"77","author":"SB Dhadde","year":"2016","unstructured":"Dhadde SB, Nagakannan P, Roopesh M, Anand Kumar SR, Thippeswamy BS, Veerapur VP, Badami S (2016) Effect of embelin against 3-nitropropionic acid-induced Huntington\u2019s disease in rats. Biomed Pharmacother 77:52\u201358. https:\/\/doi.org\/10.1016\/j.biopha.2015.11.009","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"2106_CR11","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","volume":"82","author":"GL Ellman","year":"1959","unstructured":"Ellman GL (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 82(1):70\u201377. https:\/\/doi.org\/10.1016\/0003-9861(59)90090-6","journal-title":"Arch Biochem Biophys"},{"key":"2106_CR12","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/0166-4328(88)90157-X","volume":"31","author":"A Ennaceur","year":"1988","unstructured":"Ennaceur A, Delacour J (1988) A new one-trial test for neurobiological studies of memory in rats. Behav Brain Res 31:47\u201359. https:\/\/doi.org\/10.1016\/0166-4328(88)90157-X","journal-title":"Behav Brain Res"},{"key":"2106_CR13","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.toxrep.2018.02.017","volume":"5","author":"F Firdaus","year":"2018","unstructured":"Firdaus F, Zafeer MF, Anis E, Ahmad M, Afzal M (2018) Ellagic acid attenuates arsenic induced neuro-inflammation and mitochondrial dysfunction associated apoptosis. Toxicol Rep 5:411\u2013417. https:\/\/doi.org\/10.1016\/j.toxrep.2018.02.017","journal-title":"Toxicol Rep"},{"issue":"4","key":"2106_CR14","doi-asserted-by":"publisher","first-page":"454","DOI":"10.2174\/1389450115666140115113734","volume":"15","author":"J Gil-Mohapel","year":"2014","unstructured":"Gil-Mohapel J, Brocardo PS, Christie BR (2014) The role of oxidative stress in Huntington\u2019s disease: are antioxidants good therapeutic candidates? Curr Drug Targets 15(4):454\u2013468. https:\/\/doi.org\/10.2174\/1389450115666140115113734","journal-title":"Curr Drug Targets"},{"issue":"11","key":"2106_CR15","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.4161\/rna.26706","volume":"10","author":"TA Gipson","year":"2013","unstructured":"Gipson TA, Neueder A, Wexler NS, Bates GP, Housman D (2013) Aberrantly spliced HTT, a new player in Huntington\u2019s disease pathogenesis. RNA Biol 10(11):1647\u20131652. https:\/\/doi.org\/10.4161\/rna.26706","journal-title":"RNA Biol"},{"issue":"Part A","key":"2106_CR16","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jff.2015.09.019","volume":"19","author":"A Gonzalez-Sarrias","year":"2015","unstructured":"Gonzalez-Sarrias A, Garcia-Villalba R, Nunez-Sanchez MA, Tome-Carneiro J, Zafrilla P, Mulero J, Tomas-Barberan FA, Espin JC (2015) Identifying the limits for ellagic acid bioavailability: a crossover pharmacokinetic study in healthy volunteers after consumption of pomegranate extracts. J Funct Foods 19(Part A):225\u2013235. https:\/\/doi.org\/10.1016\/j.jff.2015.09.019","journal-title":"J Funct Foods"},{"key":"2106_CR17","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.3923\/pjn.2009.1661.1664","volume":"8","author":"AWR Hamad","year":"2009","unstructured":"Hamad AWR, Al-Momani WM, Janakat S, Oran SA (2009) Bioavailability of ellagic acid after single dose administration using HPLC. Pak J Nutr 8:1661\u20131664. https:\/\/doi.org\/10.3923\/pjn.2009.1661.1664","journal-title":"Pak J Nutr"},{"issue":"52","key":"2106_CR18","doi-asserted-by":"publisher","first-page":"44512","DOI":"10.1074\/jbc.M111.307587","volume":"286","author":"S Hands","year":"2011","unstructured":"Hands S, Sajjad MU, Newton MJ, Wyttenbach A (2011) In vitro and in vivo aggregation of a fragment of huntingtin protein directly causes free radical production. J Biol Chem 286(52):44512\u201344520. https:\/\/doi.org\/10.1074\/jbc.M111.307587","journal-title":"J Biol Chem"},{"key":"2106_CR19","doi-asserted-by":"publisher","first-page":"e17160264","DOI":"10.1590\/1678-4324-2017160264","volume":"60","author":"NK Hoseiny","year":"2017","unstructured":"Hoseiny NK, Alireza S, Mahin D, Yaghoob F, Mohammad B, Mohammad Kazem GN (2017) Preventive effects of ellagic acid on nucleus tractus solitarius electrical activity and oxidative stress altered by cerebral global ischemia\/reperfusion in rat. Braz Arch Biol Technol 60:e17160264. https:\/\/doi.org\/10.1590\/1678-4324-2017160264","journal-title":"Braz Arch Biol Technol"},{"key":"2106_CR20","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.bbadis.2011.11.014","volume":"5","author":"A Johri","year":"2012","unstructured":"Johri A, Beal MF (2012) Antioxidants in Huntington\u2019s disease. Biochim Biophys Acta 5:664\u2013674. https:\/\/doi.org\/10.1016\/j.bbadis.2011.11.014","journal-title":"Biochim Biophys Acta"},{"key":"2106_CR21","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/j.toxrep.2015.08.004","volume":"2","author":"N Kaur","year":"2015","unstructured":"Kaur N, Jamwal S, Deshmukh R, Gauttam V, Kumar P (2015) Beneficial effect of rice bran extract against 3-nitropropionic acid induced experimental Huntington\u2019s disease in rats. Toxicol Rep 2:1222\u20131232. https:\/\/doi.org\/10.1016\/j.toxrep.2015.08.004","journal-title":"Toxicol Rep"},{"issue":"12","key":"2106_CR22","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1007\/s00213-017-4589-6","volume":"234","author":"Z Kiasalari","year":"2017","unstructured":"Kiasalari Z, Heydarifard R, Khalili M, Afshin-Majd S, Baluchnejadmojarad T, Zahedi E, Sanaierad A, Roghani M (2017) Ellagic acid ameliorates learning and memory deficits in a rat model of Alzheimer\u2019s disease: an exploration of underlying mechanisms. Psychopharmacology 234(12):1841\u20131852. https:\/\/doi.org\/10.1007\/s00213-017-4589-6","journal-title":"Psychopharmacology"},{"issue":"4","key":"2106_CR23","doi-asserted-by":"publisher","first-page":"325","DOI":"10.5607\/en.2015.24.4.325","volume":"24","author":"GH Kim","year":"2015","unstructured":"Kim GH, Kim JE, Rhie SJ, Yoon S (2015) The role of oxidative stress in neurodegenerative diseases. Exp Neurobiol 24(4):325\u2013340. https:\/\/doi.org\/10.5607\/en.2015.24.4.325","journal-title":"Exp Neurobiol"},{"key":"2106_CR24","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/978-1-4684-3270-1_15","volume":"74","author":"TE King","year":"1976","unstructured":"King TE, Ohnishi T, Winter DB, Wu JT (1976) Biochemical and EPR probes for structure-function studies of iron sulfur centers of succinate dehydrogenase. Adv Exp Med Biol 74:182\u2013227","journal-title":"Adv Exp Med Biol"},{"issue":"7143","key":"2106_CR25","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/nature05778","volume":"447","author":"V Kovtun","year":"2007","unstructured":"Kovtun V, Liu Y, Bjoras M, Klungland A, Wilson SH, McMurray CT (2007) OGG1 initiates age-dependent CAG trinucleotide expansion in somatic cells. Nature 447(7143):447\u2013452. https:\/\/doi.org\/10.1038\/nature05778","journal-title":"Nature"},{"issue":"3","key":"2106_CR26","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3233\/JHD-160205","volume":"5","author":"A Kumar","year":"2016","unstructured":"Kumar A, Ratan RR (2016) Oxidative stress and Huntington\u2019s disease: the good, the bad, and the ugly. J Huntingtons Dis 5(3):217\u2013237. https:\/\/doi.org\/10.3233\/JHD-160205","journal-title":"J Huntingtons Dis"},{"issue":"9","key":"2106_CR27","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1007\/s00210-018-1524-2","volume":"391","author":"M Kumar","year":"2018","unstructured":"Kumar M, Bansal N (2018a) Ellagic acid prevents dementia through modulation of PI3-kinase-endothelial nitric oxide synthase signalling in streptozotocin-treated rats. Naunyn Schmiedebergs Arch Pharmacol 391(9):987\u20131001. https:\/\/doi.org\/10.1007\/s00210-018-1524-2","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"2106_CR28","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.bbr.2018.05.024","volume":"351","author":"M Kumar","year":"2018","unstructured":"Kumar M, Bansal N (2018b) Fasudil hydrochloride ameliorates memory deficits in rat model of streptozotocin-induced Alzheimer\u2019s disease: involvement of PI3-kinase, eNOS and NF\u03baB. Behav Brain Res 351:4\u201316. https:\/\/doi.org\/10.1016\/j.bbr.2018.05.024","journal-title":"Behav Brain Res"},{"issue":"5","key":"2106_CR29","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/j.foodres.2011.04.027","volume":"44","author":"JM Landete","year":"2011","unstructured":"Landete JM (2011) Ellagitannins, ellagic acid and their derived metabolites: a review about source, metabolism, functions and health. Food Res Int 44(5):1150\u20131160. https:\/\/doi.org\/10.1016\/j.foodres.2011.04.027","journal-title":"Food Res Int"},{"issue":"11","key":"2106_CR30","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1023\/a:1007632326953","volume":"25","author":"SS Lin","year":"2000","unstructured":"Lin SS, Hung CF, Ho CC, Liu YH, Ho HC, Chung JG (2000) Effects of ellagic acid by oral administration on N-acetylation and metabolism of 2-aminofluorene in rat brain tissues. Neurochem Res 25(11):1503\u20131508. https:\/\/doi.org\/10.1023\/a:1007632326953","journal-title":"Neurochem Res"},{"issue":"3","key":"2106_CR31","doi-asserted-by":"publisher","first-page":"289","DOI":"10.17306\/J.AFS.2014.3.7","volume":"13","author":"L Lipinska","year":"2014","unstructured":"Lipinska L, Klewicka E, Sojka M (2014) The structure, occurrence and biological activity of ellagitannins: a general review. Acta Sci Pol Technol Aliment 13(3):289\u2013299. https:\/\/doi.org\/10.17306\/J.AFS.2014.3.7","journal-title":"Acta Sci Pol Technol Aliment"},{"issue":"3","key":"2106_CR32","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.nbd.2012.02.012","volume":"46","author":"D Long","year":"2012","unstructured":"Long D, Matson WR, Juhl AR, Leavitt BR, Paulsen JS (2012) 8OHdG as a marker for Huntington disease progression. Neurobiol Dis 46(3):625\u2013634. https:\/\/doi.org\/10.1016\/j.nbd.2012.02.012","journal-title":"Neurobiol Dis"},{"key":"2106_CR33","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"H Lowry","year":"1951","unstructured":"Lowry H, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265\u2013275","journal-title":"J Biol Chem"},{"issue":"3","key":"2106_CR34","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1021\/acschemneuro.0c00824","volume":"12","author":"PT Lum","year":"2021","unstructured":"Lum PT, Sekar M, Gan SH, Bonam SR, Shaikh MF (2021) Protective effect of natural products against Huntington\u2019s disease: an overview of scientific evidence and understanding their mechanism of action. ACS Chem Neurosci 12(3):391\u2013418. https:\/\/doi.org\/10.1021\/acschemneuro.0c00824","journal-title":"ACS Chem Neurosci"},{"key":"2106_CR35","doi-asserted-by":"publisher","first-page":"736837","DOI":"10.1155\/2012\/736837","volume":"2012","author":"VI Lushchak","year":"2012","unstructured":"Lushchak VI (2012) Glutathione homeostasis and functions: potential targets for medical interventions. J Amino Acids 2012:736837. https:\/\/doi.org\/10.1155\/2012\/736837","journal-title":"J Amino Acids"},{"issue":"10","key":"2106_CR36","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.3109\/13880209.2015.1137601","volume":"54","author":"MT Mansouri","year":"2016","unstructured":"Mansouri MT, Farbood Y, Naghizadeh B, Shabani S, Mirshekar MA, Sarkaki A (2016) Beneficial effects of ellagic acid against animal models of scopolamine- and diazepam-induced cognitive impairments. Pharm Biol 54(10):1947\u20131953. https:\/\/doi.org\/10.3109\/13880209.2015.1137601","journal-title":"Pharm Biol"},{"issue":"1","key":"2106_CR37","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/ene.13413","volume":"25","author":"P McColgan","year":"2018","unstructured":"McColgan P, Tabrizi SJ (2018) Huntington\u2019s disease: a clinical review. Eur J Neurol 25(1):24\u201334. https:\/\/doi.org\/10.1111\/ene.13413","journal-title":"Eur J Neurol"},{"issue":"2","key":"2106_CR38","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","volume":"95","author":"H Ohkawa","year":"1979","unstructured":"Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95(2):351\u2013358. https:\/\/doi.org\/10.1016\/0003-2697(79)90738-3","journal-title":"Anal Biochem"},{"issue":"11","key":"2106_CR39","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1002\/mds.26011","volume":"29","author":"R Reilmann","year":"2014","unstructured":"Reilmann R, Leavitt BR, Ross CA (2014) Diagnostic criteria for Huntington\u2019s disease based on natural history. Mov Disord 29(11):1335\u20131341. https:\/\/doi.org\/10.1002\/mds.26011","journal-title":"Mov Disord"},{"key":"2106_CR40","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1750-1172-5-40","volume":"5","author":"RA Roos","year":"2010","unstructured":"Roos RA (2010) Huntington\u2019s disease: a clinical review. Orphanet J Rare Dis 5:40. https:\/\/doi.org\/10.1186\/1750-1172-5-40","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"2106_CR41","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.neuint.2010.07.005","volume":"57","author":"R Sandhir","year":"2010","unstructured":"Sandhir R, Mehrotra A, Kamboj SS (2010) Lycopene prevents 3-nitropropionic acid induced mitochondrial oxidative stress and dysfunctions in nervous system. Neurochem Int 57(5):579\u2013587. https:\/\/doi.org\/10.1016\/j.neuint.2010.07.005","journal-title":"Neurochem Int"},{"issue":"1","key":"2106_CR42","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1006\/abio.2002.5676","volume":"306","author":"KV Sastry","year":"2002","unstructured":"Sastry KV, Moudgal RP, Mohan J, Tyagi JS, Rao GS (2002) Spectrophotometric determination of serum nitrite and nitrate by copper-cadmium alloy. Anal Biochem 306(1):79\u201382. https:\/\/doi.org\/10.1006\/abio.2002.5676","journal-title":"Anal Biochem"},{"issue":"1\u20132","key":"2106_CR43","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.cccn.2004.04.029","volume":"348","author":"NP Seeram","year":"2004","unstructured":"Seeram NP, Lee R, Heber D (2004) Bioavailability of ellagic acid in human plasma after consumption of ellagitannins from pomegranate (Punica granatum L.) juice. Clin Chim Acta 348(1\u20132):63\u201368. https:\/\/doi.org\/10.1016\/j.cccn.2004.04.029","journal-title":"Clin Chim Acta"},{"key":"2106_CR44","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1196\/annals.1427.008","volume":"1147","author":"EC Stack","year":"2008","unstructured":"Stack EC, Matson WR, Ferrante RJ (2008) Evidence of oxidant damage in Huntington\u2019s disease: translational strategies using antioxidants. Ann N Y Acad Sci 1147:79\u201392. https:\/\/doi.org\/10.1196\/annals.1427.008","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"2106_CR45","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1039\/c9fo02131k","volume":"11","author":"X Sun","year":"2020","unstructured":"Sun X, Zhu J, Sun XY, Ji M, Yu XL, Liu RT (2020) Ellagic acid rescues motor and cognitive deficits in the R6\/2 mouse model of Huntington\u2019s disease by lowering mutant huntingtin protein. Food Funct 11(2):1334\u20131348. https:\/\/doi.org\/10.1039\/c9fo02131k","journal-title":"Food Funct"},{"issue":"2","key":"2106_CR46","doi-asserted-by":"publisher","first-page":"878","DOI":"10.3390\/molecules15020878","volume":"15","author":"I Tunez","year":"2010","unstructured":"Tunez I, Tasset I, Perez-De La Cruz V, Santamaria A (2010) 3-Nitropropionic acid as a tool to study the mechanisms involved in Huntington\u2019s disease: past, present and future. Molecules 15(2):878\u2013916. https:\/\/doi.org\/10.3390\/molecules15020878","journal-title":"Molecules"},{"issue":"4","key":"2106_CR47","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1176\/jnp.2007.19.4.441","volume":"19","author":"E van Duijn","year":"2007","unstructured":"van Duijn E, Kingma EM, van der Mast RC (2007) Psychopathology in verified Huntington\u2019s disease gene carriers. J Neuropsychiatry Clin Neurosci 19(4):441\u2013448. https:\/\/doi.org\/10.1176\/jnp.2007.19.4.441","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"4","key":"2106_CR48","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1080\/13880200701214631","volume":"45","author":"M Vasudevan","year":"2007","unstructured":"Vasudevan M, Parle M (2007) Memory-enhancing activity of Thespesia populnea in rats. Pharm Biol 45(4):267\u2013273. https:\/\/doi.org\/10.1080\/13880200701214631","journal-title":"Pharm Biol"},{"issue":"3","key":"2106_CR49","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/j.1745-4514.2005.00031.x","volume":"29","author":"DA Vattem","year":"2005","unstructured":"Vattem DA, Shetty K (2005) Biological functionality of ellagic acid: a review. J Food Biochem 29(3):234\u2013266. https:\/\/doi.org\/10.1111\/j.1745-4514.2005.00031.x","journal-title":"J Food Biochem"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-021-02106-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-021-02106-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-021-02106-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,19]],"date-time":"2021-08-19T08:09:46Z","timestamp":1629360586000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-021-02106-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,1]]},"references-count":49,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["2106"],"URL":"https:\/\/doi.org\/10.1007\/s00210-021-02106-1","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,1]]},"assertion":[{"value":"18 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the \u201cInstitutional Animal Ethics Committee (IAEC)\u201d of the A.S.B.A.S.J.S.M. College of Pharmacy, Bela (Ropar) <i>vide<\/i> protocol no. ASCB\/IAEC\/09\/16\/113 (dated: 24\u201309-2016). The guidelines of \u201cThe Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA),\u201d Ministry of Forests & Environment, and Government of India (New Delhi) were followed for all animal experiments and care of animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors have agreed to publish this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}